Oragenics Inc (NYSE MKT LLC:OGEN)

1.05
Delayed Data
As of 2:54pm ET
 -0.10 / -8.70%
Today’s Change
0.70
Today|||52-Week Range
3.87
+18.02%
Year-to-Date
No recent news for Oragenics Inc.

Today’s Trading

Previous close1.15
Today’s open1.15
Day’s range0.93 - 1.17
Volume100,299
Average volume (3 months)37,066
Market cap$41.6M
Dividend yield--
Data as of 2:54pm ET, 03/02/2015

Growth & Valuation

Earnings growth (last year)+24.32%
Earnings growth (this year)+33.93%
Earnings growth (next 5 years)--
Revenue growth (last year)-22.49%
P/E ratioNM
Price/Sales78.34
Price/Book2.61

Competitors

 Today’s
change
Today’s
% change
ACURAcura Pharmaceutical...+0.03+2.94%
ALXAAlexza Pharmaceutica...-0.06-2.84%
IMNPImmune Pharmaceutica...-0.05-2.79%
CAPNCapnia Inc+0.11+1.75%
Data as of 3:59pm ET, 03/02/2015

Financials

Last reporting dateOctober 24, 2014
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$1.0M
Annual profit (last year)-$16.1M
Net profit margin-1,556.70%

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Secretary &
Treasurer
Michael O'Keefe Sullivan
Senior Vice President-
Discovery Research
Martin Handfield
Corporate headquarters
Tampa, Florida

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account